Clearance mechanism of protoporphyrin IX from mouse skin after application of 5-aminolevulinic acid

https://doi.org/10.1016/j.pdpdt.2013.05.008Get rights and content

Summary

Background

5-Aminolevulinic acid (ALA) or its esters mediated photodynamic therapy (PDT) is the most widely practiced form of PDT in dermatology. One of its advantages is that undesirable photosensitization lasts only for 24–48 h. In order to optimize ALA–PDT it is necessary to understand the mechanisms of intracellular production and clearance of PpIX (efflux from cells into blood stream and/or its conversion into haem). The aim of this study is to investigate the factors controlling the clearance of intracellular PpIX from healthy skin of mice.

Methods

PpIX was induced in mouse skin by topical or systemic application of ALA or by topical application of the iron chelator ethylenediaminetetraacetic acid (EDTA). Fluorescence spectroscopy was used to study PpIX kinetics in alive and dead skin.

Results

Topical application of ALA or EDTA leads to porphyrin production in living skin, but not in excised skin. The clearance rates of PpIX from alive and dead skin were the same in the absence of an intracellular ALA pool. The clearance half-life of EDTA-induced PpIX was 4–7 times longer than that of PpIX after application of ALA.

Conclusions

Skin temperature and intracellular iron availability strongly affect PpIX clearance, while ALA application mode (topical versus systemic) and skin viability (dead versus alive) have no influence on PpIX decay. These results demonstrate that the clearance kinetics of PpIX from skin are determined mostly by the conversion of PpIX into haem, while the cellular efflux of PpIX into blood plays a minor role.

Introduction

5-Aminolevulinic acid (ALA) or its esters induced protoporphyrin IX (PpIX) synthesis in neoplastic cells is used for fluorescence diagnostics, fluorescence-guided surgery and photodynamic therapy (PDT) [1], [2], [3], [4], [5]. Under normal conditions the levels of PpIX are tightly regulated, mainly by haem control of the ALA synthase activity, which is the first and also the rate-limiting enzyme of the haem synthetic pathway [6]. When applied topically or systemically, ALA bypasses the negative feedback control and induces intracellular accumulation of PpIX [1]. Since the other enzymes are essentially non-limiting, and not feedback regulated, exogenous ALA metabolism leads to overproduction of PpIX. PDT efficiency depends on intracellular PpIX levels. These levels depend on the balance between PpIX synthesis and PpIX clearance by the action of ferrochelatase in the presence of iron into haem, or by PpIX efflux from cells to blood stream. The synthesis of PpIX in vitro and in vivo has been systematically investigated in order to find methods to increase the accumulation of PpIX in target cells. Extracellular and intracellular ALA concentrations, cell type (number of mitochondria, haem synthesis enzymes activity), physiological factors (temperature, pH), and iron availability regulate the synthesis of PpIX [7]. Endogenously produced PpIX is cleared from the tissues within 24–48 h after topical and systemic application [8], [9], [10]. Due to the fast clearance of PpIX only few studies have investigated its intracellular clearance. The clearance rates of PpIX vary widely between patients with the same or different disorders [8], [11]. A deeper understanding of PpIX clearance mechanisms in the early stages after ALA application may indicate how we can reduce PpIX clearance rates and improve PDT outcome.

After ALA administration in vitro and in vivo PpIX is synthesized in the mitochondria [1]. Then PpIX diffuses from the mitochondria and, being lipophilic, is relocalized in cell membranes and cytoplasm [12], [13], [14]. In vitro, extracellular serum proteins bind PpIX molecules and speed up leakage from the cells (PpIX efflux) [15], [16], [17], [18], [19], [20], [21], [22], [23], [24]. In the presence of serum both PpIX clearance mechanisms, cellular efflux and conversion into haem, take place in vitro. In the absence of serum, PpIX is mostly converted into haem [25], [26]. So far, little emphasis has been focused on the detailed clearance mechanisms of PpIX after ALA application and its control mechanisms in vivo.

Ferrochelatase converts PpIX into haem by inserting ferrous iron into PpIX, and the presence of iron chelators alone promotes the accumulation of PpIX [27]. The comparison of clearance rates of iron chelator-induced PpIX and ALA-induced PpIX may help to understand the clearance mechanisms of PpIX. If PpIX is mostly converted into haem (not via the efflux of PpIX from cells into blood), iron chelator-induced PpIX will be converted into haem much slower than ALA-induced PpIX due to the iron deficiency. Topical application of cream containing a well known iron chelator, ethylenediaminetetraacetic acid (EDTA), has been chosen to induce PpIX and study its clearance.

In the present work we report that PpIX induced by exogenous application of ALA in skin is converted into haem rather than diffuse from the skin into blood stream.

Section snippets

Preparation of the drugs

The used drugs 5-aminolevulinic acid (ALA) hydrochloride (Sigma Chemical Co., St. Louis, MO) or ethylenediaminetetraacetic acid (EDTA, Sigma Chemical Co., St. Louis, MO) were directly dissolved phosphate buffered saline (PBS) or in a base cream (Unguentum M, Merck, Darmstadt, Germany). Around 50 μl of 200 mg/kg ALA was injected intraperitoneally (i.p.) into mice. Approximately 100 mg of 20% (w/w) ALA or 20% EDTA cream was applied topically on a single spot (area around 1 cm2) on the right flank of

PpIX induction by ALA or EDTA

Normalized fluorescence emission spectra, registered from normal mouse skin after topical or systemic application of ALA and EDTA, are shown in Fig. 1. These spectra are very similar in shape and both have their maxima at 636 nm and 705 nm, confirming that PpIX is the main fluorescent porphyrin induced by EDTA and ALA.

The maximum fluorescence intensities of PpIX after systemic and topical application of ALA were reached at around 3 h and 6–24 h, respectively (Fig. 2, Fig. 3). PpIX fluorescence

Discussion

PpIX is a highly hydrophobic molecule, and one can expect that it is mainly bound or retained in lipophilic structures in cells and tissues. Supposedly, it is not cleared from the body by renal excretion. However, ALA-induced PpIX is cleared from the body within 24–48 h [8], [9], [10]. Thus, a question of the basic pharmacokinetics, especially that of the “clearance” phase of PpIX is of large scientific interest. A number of investigators have already paid attention to the conversion of PpIX

Conclusions

ALA application mode (topical versus systemic) and skin viability (dead versus alive) have no influence on PpIX decay in normal mouse skin. Since ferrochelatase catalyzes the insertion of iron ions into the PpIX molecule to produce haem, the labile intracellular iron pool influences the PpIX levels. In our study EDTA was used to diminish the availability of intracellular iron pool. This delayed the conversion of PpIX into haem. The incorporation of iron into PpIX also depends on skin

Acknowledgements

The present work was supported by the South-Eastern Norway Regional Health Authority and the Norwegian Cancer Society and Oslo University Hospital.

References (53)

  • P. Juzenas et al.

    Reduction of cutaneous photosensitivity by application of ointment containing ferrous or cobaltous ions concomitant with the use of topical protoporphyrin IX precursors

    Photodiagnosis Photodyn Ther

    (2010)
  • T. Houston et al.

    Regulation of haem biosynthesis in normoblastic erythropoiesis: role of 5-aminolaevulinic acid synthase and ferrochelatase

    Biochim Biophys Acta

    (1994)
  • S. Taketani et al.

    Rat liver ferrochelatase. Purification, properties, and stimulation by fatty acids

    J Biol Chem

    (1981)
  • Y. Wang et al.

    QM/MM study of the insertion of metal ion into protoporphyrin IX by ferrochelatase

    J Inorg Biochem

    (2009)
  • J. van den Boogert et al.

    5-Aminolaevulinic acid-induced protoporphyrin IX accumulation in tissues: pharmacokinetics after oral or intravenous administration

    J Photochem Photobiol B

    (1998)
  • N. Dognitz et al.

    Comparison of ALA- and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma

    J Photochem Photobiol B

    (2008)
  • E.S. Lee et al.

    Recent progress in tumor pH targeting nanotechnology

    J Control Release

    (2008)
  • O. Bech et al.

    A hydroxypyridinone (CP94) enhances protoporphyrin IX formation in 5-aminolaevulinic acid treated cells

    J Photochem Photobiol B

    (1997)
  • Q. Peng et al.

    5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges

    Cancer

    (1997)
  • B. Zhao et al.

    Recent advances in the prevention and treatment of skin cancer using photodynamic therapy

    Expert Rev Anticancer Ther

    (2010)
  • A. Klein et al.

    Photodynamic therapy in dermatology—an update 2008

    J Dtsch Dermatol Ges

    (2008)
  • P.A. Valdes et al.

    delta-Aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy

    Neuro Oncol

    (2011)
  • N.S. van den Berg et al.

    Fluorescence guidance in urologic surgery

    Curr Opin Urol

    (2012)
  • S. Collaud et al.

    On the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formation

    Curr Med Chem Anticancer Agents

    (2004)
  • D. Ormrod et al.

    Topical aminolevulinic acid HCl photodynamic therapy

    Am J Clin Dermatol

    (2000)
  • C.A. Morton et al.

    Guidelines for topical photodynamic therapy: update

    Br J Dermatol

    (2008)
  • Cited by (8)

    • Polymeric nanoparticles favor the in vitro dermal accumulation of Protoporphyrin IX (PpIX) with optimal biocompatibility and cellular recovery in culture of healthy dermal fibroblasts after Photodynamic Therapy

      2020, Journal of Photochemistry and Photobiology A: Chemistry
      Citation Excerpt :

      Similarly, after 24 h, penetration was lower than 8 h, probably due to the decrease in PpIX fluorescence over this long interval. As the experiment was performed ex vivo, there is no possibility of metabolic elimination of PpIX, as well as the use of PpIX to synthesize the hemoglobin heme group [28]. Thus, although skin was kept in the dark during the experiment to avoid any degradation of PpIX, other factors may have influenced the decrease in fluorescence over 24 h, such as temperature, pH, and solvent, which may have profound effects on the fluorescence characteristics of a substance [29].

    • Plum-blossom needle assisted photodynamic therapy for the treatment of oral potentially malignant disorder in the elderly

      2019, Photodiagnosis and Photodynamic Therapy
      Citation Excerpt :

      Aminolevulinic-acid (ALA) is the metabolic precursor of the photosensitizer-protoporphyrin IX (PpIX) in the heme biosynthesis pathway. As an endogenous metabolite ubiquitous in mammalian cells, ALA can reduce the synthesis time of PpIX, therefore allowing it to accumulate in certain tissues and cells [25]. Compared to other photosensitizing agents, ALA can cause mild phototoxic side effects to the normal tissues and their biochemical properties.

    • α-Bisabolol improves 5-aminolevulinic acid retention in buccal tissues: Potential application in the photodynamic therapy of oral cancer

      2017, Journal of Photochemistry and Photobiology B: Biology
      Citation Excerpt :

      The lipophilic terpene α-Bis has improved the permeability of hydrophilic drugs in skin models, even when used at concentrations as low as 5% (w/w) [25]. Considering that the drug-light interval, i.e. the time between the application of the PS and the laser incidence in PDT of oral tumors [18], can vary from 1 to 6 h [7,19,20,21], in this study we selected the mean time (4 h) to examine the in vitro permeability of 5-ALA after application of the formulations onto porcine buccal mucosa. At the 4-h and 24-h treatment periods, the tenfold increase of 5-ALA concentration in the formulation enhanced the drug permeation (Fig. 1); such increment was not linear with the α-Bis concentration.

    • Chitosan-based mucoadhesive films containing 5-aminolevulinic acid for buccal cancer's treatment

      2014, Journal of Photochemistry and Photobiology B: Biology
      Citation Excerpt :

      By either route of administration, maximum tissue concentrations of PpIX are obtained within 4–6 h, followed by an almost equally rapid decline. Within 48 h, tissue levels of PpIX are back to background levels [8,9]. The lack of long-lasting photosensitization is the great advantage of 5-ALA over all other photosensitizers [10].

    • Comparison of 5-aminolevulinic acid photodynamic therapy and red light for treatment of photoaging

      2014, Photodiagnosis and Photodynamic Therapy
      Citation Excerpt :

      The distribution of collagen and elastic fibers in the dermal layers appeared more uniform, regular and tighter after ALA-PDT. It was suggested that short incubation time (≤2 h) was appropriate for photorejuvenation although PpIX kinetics in aging skin might be different to that in normal skin [9–11]. In this study, 10% ALA and 2 h incubation were used for photodamaged skin.

    View all citing articles on Scopus
    View full text